Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
This study aimed to develop a biopredictive dissolution method for desvenlafaxine ER tablets using design of experiments (DoE) and physiologically based biopharmaceutics modeling (PBBM) to address the challenge of developing generic drug products by reducing the risk of product failure in pivotal bi...
Main Authors: | Gustavo Vaiano Carapeto, Marcelo Dutra Duque, Michele Georges Issa, Humberto Gomes Ferraz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/5/1544 |
Similar Items
-
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
by: Marival Bermejo, et al.
Published: (2020-06-01) -
Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model
by: Olha Shuklinova, et al.
Published: (2022-07-01) -
Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling
by: Michele Georges Issa, et al.
Published: (2022-04-01) -
Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets
by: Wael Samy, et al.
Published: (2017-07-01) -
Drug–drug interactions involving antidepressants: focus on desvenlafaxine
by: Low Y, et al.
Published: (2018-02-01)